Lab Notes: Adaptimmune to expand manufacturing at Navy Yard; Helius raises $18M with stock sale

This week's updates from the region's life sciences industry include news on a cell therapy company's manufacturing capacity expansion at its Philadelphia Navy Yard site, a medical device company's multimillion-dollar stock sale, a co-chairman and co-CEO appointment, and more.

Here's the roundup:

The cell therapy company remains on track to submit its first biologics license application for an experimental cancer therapy by the end of this year and, in connection with that milestone, it is expanding…

Previous Commercial Interior Design Firms
Next Johnson & Johnson to stop selling talc-based baby powder